摘要:
The present invention provides a novel lymphocyte inhibitory receptor termed BTLA which is expressed on both T and B cells, and identifies HVEM as interacting with BTLA. Methods and compositions for modulating BTLA-mediated signaling and interfering with the interaction of BTLA and HVEM for therapeutic, diagnostic and research purposes are also provided.
摘要:
Provided are methods of modulating dendritic cell activity using agonists or antagonists of a mammalian cytokine. Also provided are methods of treating immune disorders.
摘要:
The present invention provides a novel lymphocyte inhibitory receptor termed BTLA which is expressed on both T and B cells, and identifies B7 family member B7x as interacting with BTLA to attenuate lymphocyte activity. Methods and compositions for modulating BTLA-mediated negative signaling and interfering with the interaction of BTLA and B7x for therapeutic, diagnostic and research purposes are also provided.
摘要:
An engine valve train having a camshaft supported on a camshaft holder and driving inlet valves to open and close via inlet rocker arms; an electromagnetic actuator mechanism including an armature; a holding rod connected to the armature and pressing against a stem end of the inlet valve so as to hold the inlet valve in an open state; and, a hydraulic damper mechanism absorbing an impact which is generated by the inlet valve when the inlet valve is released from being held by the electromagnetic actuator mechanism so as to be restored to a closed state and is then seated, wherein the hydraulic damper mechanism is supported on the camshaft holder.
摘要:
The present invention provides a novel lymphocyte inhibitory receptor termed BTLA which is expressed on both T and B cells, and identifies HVEM as interacting with BTLA. Methods and compositions for modulating BTLA-mediated signaling and interfering with the interaction of BTLA and HVEM for therapeutic, diagnostic and research purposes are also provided.
摘要:
The present invention provides a novel lymphocyte inhibitory receptor termed BTLA which is expressed on both T and B cells, and identifies B7 family member B7x as interacting with BTLA to attenuate lymphocyte activity. Methods and compositions for modulating BTLA-mediated negative signaling and interfering with the interaction of BTLA and B7x for therapeutic, diagnostic and research purposes are also provided.
摘要:
A method of identifying a compound for preventing and/or treating an autoimmune disease is described which comprises obtaining a (BTLA−/−) NKT cell from a non-human animal, contacting the (BTLA−/−) NKT cell ex vivo with a test compound, in the presence of an antigen, measuring a response of the (BTLA−/−) NKT cell to the antigen, comparing the response of the (BTLA−/−) NKT cell to the antigen with a response of a (BTLA−/−) NKT cell in control assay, and selecting the compound that reduces the response of the (BTLA−/−) NKT cell in the presence of an antigen compared to a response of a (BTLA−/−) NKT cell in the control assay. Other methods of identifying a compound for preventing and/or treating an autoimmune disease are also described.
摘要:
Provided are methods of modulating dendritic cell activity using agonists or antagonists of a mammalian cytokine. Also provided are methods of treating immune disorders.
摘要:
Provided are methods of modulating dendritic cell activity using agonists or antagonists of a mammalian cytokine. Also provided are methods of treating immune disorders.
摘要:
The present invention provides a novel lymphocyte inhibitory receptor termed BTLA which is expressed on both T and B cells, and identifies HVEM as interacting with BTLA. Methods and compositions for modulating BTLA-mediated signaling and interfering with the interaction of BTLA and HVEM for therapeutic, diagnostic and research purposes are also provided.